Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Е. V. Artamonova
Observed names:
Artamonova E.,
E. Artamonova,
E. V. Artamonova,
E.V. Artamonova,
Е. V. Artamonova
Institutions:
Pirogov Russian National Research Medical University,
Russian Cancer Research Center NN Blokhin,
Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky,
Ministry of Health of the Russian Federation
Observed institutions:
Pirogov Russian National Research Medical University,
Russian Cancer Research Center NN Blokhin,
Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky,
Ministry of Health of the Russian Federation
ORCID:
0000-0001-7728-9533
Observed ORCID:
0000-0001-7728-9533
OpenAlex ID:
A5058414607
Alpelisib as a new treatment option for patients with the PIK3CA mutation. The effectiveness and tolerability of therapy on the example of a clinical case
2021
·
Е. I. Kovalenko
, Е. V. Artamonova
·
Meditsinskiy sovet = Medical Council
·
4
Perioperative chemotherapy with FLOT regimen in patients with resectable gastric or gastroesophageal junction adenocarcinoma (SIEWERT type I–III). Experience of the N. N. Blokhin russian cancer research center
2022
·
I. G. Avdyukhin
, I. N. Peregorodiev
, et al.
·
Malignant tumours
·
3
PDF
Subpopulation structure of tumor-infiltrating lymphocytes in early and locally advanced triple negative breast cancer and its effect on the efficiency of neoadjuvant chemotherapy
2023
·
M. V. Khoroshilov
, E. I. Kovalenko
, et al.
·
Malignant tumours
·
2
PDF
65P Temozolomide as second and subsequent lines of treatment in metastatic adrenocortical cancer. Single-center retrospective trial
2026
·
Y.A. Zhulikov
, E.I. Kovalenko
, et al.
·
ESMO rare cancers.
·
1
PDF
44P Reintroduction of platinum-based chemotherapy ± mitotane for advanced adrenocortical cancer: Single-center retrospective trial
2025
·
Y.A. Zhulikov
, E.I. Kovalenko
, et al.
·
ESMO Open
·
1
PDF
45P Alofanib in subsequent therapy of advanced gastric cancer: Final results from the phase Ib clinical trial
2022
·
L.Y. Vladimirova
, V. Kurakin
, et al.
·
Annals of Oncology
·
1
Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting
2021
·
N. S. Besova
, Т. А. Titova
, et al.
·
Meditsinskiy sovet = Medical Council
·
1
280P Phase II mFOLFIRINOX for advanced gastroenteropancreatic NET G3 and NEC, final results
2026
·
Y.A. Zhulikov
, E.V. Evdokimova
, et al.
·
Annals of Oncology
PDF
Efficacy of mFOLFIRINOX chemotherapy for treatment of high-grade G3 neuroendocrine tumors and gastroenteropancreatic neuroendocrine carcinomas
2026
·
Abidat K. Kachmasova
, Ya. A. Zhulikov
, et al.
·
Surgery and Oncology
Retrospective non-comparative single-center study of platinum-based regimen efficacy in the 1st line therapy of high-grade neuroendocrine carcinomas of gynecologic tract
2026
·
Khadizhat A. Suleymanova
, Ya. A. Zhulikov
, et al.
·
Surgery and Oncology
61P Prognostic value of DNA methylation profiles in resectable adrenocortical carcinomaprognostic value of DNA methylation profiles in resectable adrenocortical carcinoma
2026
·
Y.A. Zhulikov
, V. Bohian
, et al.
·
ESMO rare cancers.
PDF
1176eP Retrospective single-center study comparing the effectiveness of sunitinib and chemotherapy based on alkylating agents in the treatment of metastatic pheochromocytomas/paragangliomas
2025
·
Y.A. Zhulikov
, E.I. Kovalenko
, et al.
·
Annals of Oncology
50P Combination of platinum-based chemotherapy with immunotherapy in treatment of extrapulmonary neuroendocrine carcinoma: A retrospective study
2025
·
E.V. Evdokimova
, Y.A. Zhulikov
, et al.
·
ESMO Open
PDF
Efficiency of platinum-based chemotherapy re-induction for adrenocortical cancer treatment
2022
·
Zhulikov Ya.
, Kovalenko E.
, et al.
·
SCIREA Journal of Clinical Medicine
PDF
How to achieve balance between the efficacy of metastatic breast cancer treatment and the quality of life
2022
·
E.V. Artamonova
, E.V Tkachenko
, et al.
·
Russian Medical Inquiry
PDF
Show more works
View as search
Works count:
15
Citation count:
13
H-index:
2
I10-index:
Year
Topic
Type